I am a medical epidemiologist (MD in 1988 at Paris V, specialisation in rheumatology in 1990, Paris V, and DrPH from Harvard School of Public Health in 1993) specialized in infectious diseases epidemiology. After working at WHO at the clinical research unit of the Global Program on AIDS (1993-1994), I spent five years in Ethiopia and two years in the Netherlands working as the Program Manager of the Ethio-Netherlands AIDS Research Project (1994-2001). In 2002, I joined Institut Pasteur to launch the Emerging Diseases Epidemiology unit. There, my focus has been on viral hepatitis C (North-Coordinator of the ANRS research site on viral hepatitis; www.hepnile.org) and emerging infections such as the SARS (Scientific Coordinator of the EPISARS project which aimed prevent the re-emergence of SARS through the control of its animal reservoir) and the MERS-CoV. I also have a strong teaching involvement, as co-Director and founder of the Pasteur-Cnam School of Public Health (http://ecole-pasteur.cnam.fr), and coordinator of a master in public health with strong focus on infectious diseases. In 2014, I was appointed as Director of the newly created Pasteur Centre for Global Health Research and Education.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Projets Transversaux
Projets
Publications
Télécharger-
2018Hypoglycemic Toxins and Enteroviruses as Causes of Outbreaks of Acute Encephalitis-Like Syndrome in Children, Bac Giang Province, Northern Vietnam, Emerging Infect. Dis. 2018 08;24(8):1435-1443.
-
2018Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt, Aliment. Pharmacol. Ther. 2018 Jun;47(11):1564-1566.
-
2018Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa, Am. J. Trop. Med. Hyg. 2018 Aug;99(2):428-434.
-
2018A multi-faceted pandemic: a review of the state of knowledge on the Zika virus, Public Health Rev 2018;39:10.
-
2018Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data, Liver Int. 2018 May;.
-
2018The burden of hepatitis C virus in Cameroon: Spatial epidemiology and historical perspective, J. Viral Hepat. 2018 08;25(8):959-968.
-
2018Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus, Gut 2018 Nov;67(11):2017-2024.
-
2018Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas, N. Engl. J. Med. 2018 03;378(11):985-994.
-
2018Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study, Clin. Infect. Dis. 2018 Mar;66(6):825-832.
-
2018Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis, J. Viral Hepat. 2018 06;25(6):623-630.
-
+Voir la liste complète de publications